AMLX
Amylyx Pharmaceuticals Inc
27.80$
+0.0%
vs. previous close
Closing price · As of: Oct 5, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| -749.4% | -5,645.7% | -26,245.3% | -809.1% | 3.1% | -191.9% | – | |
| 0.1% | 0.2% | 18.2% | 2.2% | 0.3% | 1.0% | – | |
| 7.6% | 37.4% | 1,100.4% | 97.7% | 9.8% | 37.8% | – | |
| -33.3% | 458.9% | 2,977.2% | 97.7% | – | – | – | |
| 245.7% | 399.8% | 1,612.3% | -7.4% | -17.2% | -52.5% | – | |
| 10.6% | 23.2% | 123.9% | 11.4% | 0.3% | 0.2% | – | |
| -10.6% | -23.2% | -16,282.8% | -1,075.1% | 24.2% | 86.6% | – | |
| – | – | – | 1,955.2% | -0.9% | – | – | |
| 45.0% | 2,587.2% | 9,086.3% | 0.0% | 0.0% | – | – | |
| 46.8% | 7,203.5% | 55,616.1% | 1,942.4% | 0.9% | 0.4% | – | |
| 216.8% | 1,534.6% | 13,092.6% | 57.9% | 28.3% | -105.4% | – | |
| -749.4% | -5,668.9% | -26,369.1% | -820.5% | 2.8% | -192.1% | – |
Data as of: October 5, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.